Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Small molecule inhibitors of West Nile virus.

Elseginy SA, Massarotti A, Nawwar GA, Amin KM, Brancale A.

Antivir Chem Chemother. 2014 Apr 11;23(5):179-87. doi: 10.3851/IMP2581. Review.

PMID:
23636899
2.

Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.

Parkinson T, Pryde DC.

Future Med Chem. 2010 Jul;2(7):1181-203. doi: 10.4155/fmc.10.195. Review. Erratum in: Future Med Chem. 2011 Apr;3(6):770.

PMID:
21426163
3.

Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A, Block TM.

Antiviral Res. 2006 Jun;70(2):39-50.

PMID:
16724398
4.

Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.

Schüller A, Yin Z, Brian Chia CS, Doan DN, Kim HK, Shang L, Loh TP, Hill J, Vasudevan SG.

Antiviral Res. 2011 Oct;92(1):96-101. doi: 10.1016/j.antiviral.2011.07.002. Epub 2011 Jul 8.

PMID:
21763725
5.
6.

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.

Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F.

J Infect Dis. 2005 Jan 15;191(2):207-14. Epub 2004 Dec 10.

PMID:
15609230
7.

Identification and characterization of inhibitors of West Nile virus.

Puig-Basagoiti F, Qing M, Dong H, Zhang B, Zou G, Yuan Z, Shi PY.

Antiviral Res. 2009 Jul;83(1):71-9. doi: 10.1016/j.antiviral.2009.03.005. Epub 2009 Apr 1.

8.

Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.

Samanta S, Cui T, Lam Y.

ChemMedChem. 2012 Jul;7(7):1210-6. doi: 10.1002/cmdc.201200136. Epub 2012 Apr 30.

PMID:
22550001
9.

Strategies for the identification of inhibitors of West Nile virus and other flaviviruses.

Shi PY.

Curr Opin Investig Drugs. 2002 Nov;3(11):1567-73. Review.

PMID:
12476954
10.

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

Magnusson SE, Karlsson KH, Reimer JM, Corbach-Söhle S, Patel S, Richner JM, Nowotny N, Barzon L, Bengtsson KL, Ulbert S, Diamond MS, Stertman L.

Vaccine. 2014 Feb 7;32(7):800-8. doi: 10.1016/j.vaccine.2013.12.030. Epub 2013 Dec 28.

PMID:
24380682
11.

Genetic systems of West Nile virus and their potential applications.

Shi PY.

Curr Opin Investig Drugs. 2003 Aug;4(8):959-65. Review.

PMID:
14508880
12.

Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.

Jordan I, Briese T, Fischer N, Lau JY, Lipkin WI.

J Infect Dis. 2000 Oct;182(4):1214-7. Epub 2000 Aug 22.

PMID:
10979920
13.

Novel approaches to flavivirus drug discovery.

Botting C, Kuhn RJ.

Expert Opin Drug Discov. 2012 May;7(5):417-28. doi: 10.1517/17460441.2012.673579. Epub 2012 Mar 22. Review.

PMID:
22439769
14.

Surveillance for human West Nile virus disease - United States, 1999-2008.

Lindsey NP, Staples JE, Lehman JA, Fischer M; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2010 Apr 2;59(2):1-17. Erratum in: MMWR Surveill Summ. 2010 Jun 18;59(23):720.

15.

Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease.

Ezgimen M, Lai H, Mueller NH, Lee K, Cuny G, Ostrov DA, Padmanabhan R.

Antiviral Res. 2012 Apr;94(1):18-24. doi: 10.1016/j.antiviral.2012.02.003. Epub 2012 Feb 11.

16.

[Investigation of West Nile virus seroprevalence in healthy blood donors].

Hızel K, Yenicesu I, Erdal B, Yeşilyurt E, Fidan I, Kalkancı A, Dilsiz G.

Mikrobiyol Bul. 2010 Jul;44(3):425-30. Turkish.

PMID:
21063992
17.

West Nile virus neuroinvasive disease.

Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL.

Ann Neurol. 2006 Sep;60(3):286-300. Review.

PMID:
16983682
18.

Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.

Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP.

Equine Vet J. 2007 Nov;39(6):491-7.

PMID:
18065305
19.

West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression.

Shives KD, Beatman EL, Chamanian M, O'Brien C, Hobson-Peters J, Beckham JD.

J Virol. 2014 Aug;88(16):9458-71. doi: 10.1128/JVI.01323-14. Epub 2014 Jun 11.

20.

Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.

Gao Y, Samanta S, Cui T, Lam Y.

ChemMedChem. 2013 Sep;8(9):1554-60. doi: 10.1002/cmdc.201300244. Epub 2013 Jul 18.

PMID:
23868614

Supplemental Content

Support Center